A significant shift in how the Department of Veterans Affairs (VA) calculates disability compensation took effect this week, potentially affecting millions of veterans. On February 17, 2026, the VA published an interim final rule that requires medical examiners to account for the “improving effects” of medication when determining a veteran’s disability rating. The rule, titled “Evaluative Rating: Impact of Medication” (RIN 2900-AS49), marks a departure from recent judicial precedents that often required the VA to rate veterans based on their underlying “baseline” condition, regardless of whether medication suppressed their symptoms.

The Core of the Change

For decades, the “baseline” vs. “medicated” debate has been a point of legal contention. Historically, if a veteran’s symptoms were managed by a prescription, the VA might argue the disability was less severe. However, recent court rulings, including the landmark Ingram v. Collins (2025), leaned toward protecting veterans from being “penalized” for seeking treatment. This new rule effectively bypasses those court rulings by updating 38 CFR § 4.10. The VA states the goal is to “ensure ratings reflect a veteran’s actual functional impairment.” Critics, however, argue this creates a “wellness trap,” where a veteran who successfully manages a condition like PTSD or hypertension could see their monthly compensation decreased as a result of their medical compliance.

Critical Timelines & Deadlines

Because this was issued as an Interim Final Rule, it is currently active. However, the law requires a public comment period before the rule is permanently codified.

• Effective Date: February 17, 2026.

• Public Comment Deadline: April 20, 2026.

• Implementation: VA raters and C&P (Compensation and Pension) examiners are instructed to begin applying these standards to pending and new claims immediately.

How Veterans Can Respond

The VA is legally required to review every unique public comment submitted during this window. Meaningful pushback involves three specific levels of action:

1. Submit a Formal Public Comment Veterans, caregivers, and medical professionals can submit comments via the Federal Register (Docket No. VA-2026-VBA-0067).

• Focus on “Functional Loss”: Effective comments often highlight that while medication may mask symptoms, it rarely “cures” the service-connected injury.

• Highlight Side Effects: Under the new rule, the VA must also consider the “negative impact” of the medication itself. Documenting lethargy, nausea, or organ strain caused by prescriptions is vital.

2. Contact Congressional Oversight The House and Senate Committees on Veterans’ Affairs have the authority to hold oversight hearings. Veterans can contact their representatives to ask for a “Legislative Stay” on the rule, arguing that it was implemented without sufficient veteran input.

3. Protect Individual Ratings If a veteran receives a Notice of Proposed Reduction due to this rule, they have:

• 30 Days to request a hearing (which stays the reduction).

• 60 Days to submit new evidence. Evidence should focus on “flares”—periods where medication fails—and the total functional impact of the disability on daily life and work.

Call to Action: Contact Your Representatives and VSOs

The window to influence this policy closes on April 20, 2026. Veterans are urged to take the following steps immediately to advocate for their earned benefits:

• Contact Your Members of Congress: Find your Representative at House.gov and your Senators at Senate.gov. Demand that they intervene in the implementation of RIN 2900-AS49 and hold the VA accountable through the House and Senate Veterans’ Affairs Committees.

• Engage with Veterans Service Organizations (VSOs): Organizations like the DAV (Disabled American Veterans), VFW (Veterans of Foreign Wars), and American Legion are already mobilizing. Contact your local chapter or the national legislative office to join their coordinated advocacy campaigns. You can find a VSO using the VA’s official search tool.

• Submit Your Official Comment: Visit the Federal Register – RIN 2900-AS49 to submit your formal feedback.